Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Mincon Group Plc Director's Dealing 2020

Apr 16, 2020

1972_dirs_2020-04-16_e3d6c4a5-60e1-489d-b8ac-87fd17da74e2.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 8688J

Mincon Group Plc

16 April 2020

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Hugh McCullough

2

Reason for the notification

a)

Position/status

Non-Executive Chairman / PDMR

b)

Initial Notification Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mincon Group plc

b)

LEI

635400LCBSV68KQHN886

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial  instrument,

type  of

instrument

Identification code

Ordinary Shares of Nominal Value €0.01 each.

ISIN:        IE00BD64C665

b)

Nature of the transaction  

Acquisition of Ordinary Shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
€0.85 29,263

d)

Aggregated information

- Aggregated volume

- Price

N/A

N/A

e)

Date of the transaction

15 April 2020

f)

Place of the transaction

Euronext Dublin - XESM

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHKKABBFBKKDQD